Oral mucositis (OM) is a side effect seen in the majority of pediatric hematopoietic stem cell transplant (HSCT) patients after conditioning chemotherapy. OM has been described as one of the most debilitating side effects of an HSCT, and can cause edema, erythema, and painful ulcers on the oral mucosa,...
Long‐term survival rates for pediatric heart transplant (HT) recipients continue to improve, increasing the number that will transition care to an adult specialist. The transition from pediatric to adult care occurs during a vulnerable time of emerging adulthood (between 18 and 25 years of age)...
Lung transplantation is a treatment option for pediatric patients with end‐stage pulmonary disease and pulmonary vascular disease, including cystic fibrosis (CF), interstitial lung disease, and pulmonary hypertension. After transplantation, patients require lifelong immunosuppression to reduce...
Acute rejection is associated with premature graft failure and impaired quality of life for pediatric kidney transplant recipients. Early acute cellular rejection is directly associated with later development of donor‐specific antibodies and chronic inflammation in areas of interstitial fibrosis...